These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11916086)

  • 1. 15 deoxy delta12,14 PGJ2 induces procoagulant activity in cultured human endothelial cells.
    Xie S; O'Regan DJ; Kakkar VV; Scully MF
    Thromb Haemost; 2002 Mar; 87(3):523-9. PubMed ID: 11916086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.
    Migita H; Morser J
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):710-6. PubMed ID: 15662020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade.
    Eligini S; Banfi C; Brambilla M; Camera M; Barbieri SS; Poma F; Tremoli E; Colli S
    Thromb Haemost; 2002 Sep; 88(3):524-32. PubMed ID: 12353085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE; Gould H; Harris T; Bonacci JV; Stewart AG
    Br J Pharmacol; 2004 Feb; 141(3):517-25. PubMed ID: 14718259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
    Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
    Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-Deoxy-Delta(12,14)-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292).
    Chiba T; Ueki S; Ito W; Kato H; Takeda M; Kayaba H; Furue M; Chihara J
    Int Arch Allergy Immunol; 2009; 149 Suppl 1():77-82. PubMed ID: 19494510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
    Kang DS; Kwon CH; Park JY; Kim JH; Woo JS; Jung JS; Kim YK
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):426-35. PubMed ID: 16890972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J; Cook JA; O'Connor M; Zingarelli B
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PPARgamma ligand, 15-Deoxy-Delta12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells.
    Okano H; Shiraki K; Inoue H; Kawakita T; Deguchi M; Sugimoto K; Sakai T; Murata K; Nakano T; Enjoji M
    Int J Mol Med; 2003 Dec; 12(6):867-70. PubMed ID: 14612959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
    J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
    Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of epidermal growth factor receptor by cyclopentenone prostaglandin 15-Deoxy-Delta12,14-prostaglandin J2 in human oral squamous carcinoma cells.
    Siavash H; Nikitakis NG; Sauk JJ
    Cancer Lett; 2004 Jul; 211(1):97-103. PubMed ID: 15194221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects.
    Calabrò P; Samudio I; Safe SH; Willerson JT; Yeh ET
    J Vasc Res; 2005; 42(6):509-16. PubMed ID: 16155367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton.
    Stamatakis K; Sánchez-Gómez FJ; Pérez-Sala D
    J Am Soc Nephrol; 2006 Jan; 17(1):89-98. PubMed ID: 16291835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15d-PGJ2 induces apoptosis of mouse oligodendrocyte precursor cells.
    Xiang Z; Lin T; Reeves SA
    J Neuroinflammation; 2007 Jul; 4():18. PubMed ID: 17634127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.